Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

The Value of a Strategic Partner

IMP

Over the past five years, leaders on both the clinical and business sides of radiology have learned the hard way that adaptability and flexibility are prized qualities required for survival.

Fluorine-labeled bombesin PET agent a winner for prostate cancer imaging

In a comparison of gastrin-releasing peptide receptor (GRPR) bombesin analogs, F-18 aluminum flouride-labeled NODAGA-RM1 showed the most promise for PET imaging of prostate cancer, according to a study published online Nov. 6 in the Journal of Nuclear Medicine.

Being bilingual could delay onset of dementia

People fluent in two languages may be warding off the cognitive decline associated with dementia for up to six years longer than single-language speakers, according to a study published online Nov. 6 in Neurology.

Thumbnail

PQRS: Play Now or Pay Later

Human nature being what it is, physician participation in Medicare’s Physician Quality Reporting System (PQRS) will likely accelerate as the agency phases incentives out and penalties in. The effect may prove especially conspicuous since the bonuses have been voluntary and modest. By contrast, the forfeitures will be automatic and, if paired with other pay-for-performance requirements, impossible to ignore.

Thumbnail

The Year in Images 2013

Each year, a few images emerge from the masses as the most striking portraits of the newest molecular imaging research.

Thumbnail

Tau Imaging Takes the Stage

Tao is making headlines. The journal Neuron recently published a clinical study heralding a viable tau PET agent. Co-author Makoto Higuchi from the Molecular Imaging Center of the National Institute of Radiological Sciences in Chiba, Japan, provided us with an exclusive look into this game-changer that will no doubt inform new formulas for dementia imaging.

Thumbnail

Fingerprinting Cancer: How Radiomics and Genomics Are Mapping Tumor Heterogeneity Using ‘Big Data’ to Track Killer Habitats

Cancer is often characterized as a serial murderer that needs to be struck down with brute force. But what researchers are slowly coming to understand is that this idea might actually make individual cancers stronger.

Thumbnail

Imaging Addiction: Could PET & MR End Cocaine Abuse?

Cocaine addiction can ruin a person physically and financially, and with an estimated 1.4 million cocaine users in the U.S., thousands will become trapped by their habit. While previous research on the drug and its addictive potential were observational and subjective, imaging is reshaping how we see addiction—and how it will be treated.